MAEGAN WAGNER: Open Payments
NPI 1871935049 · MOUNTAIN HOME, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 24 payments from 9 companies in 2025. Trend: 2023 $422 · 2024 $429 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $97 |
| UCB, Inc. | 4 | $89 |
| Amgen Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $62 |
| ABBVIE INC. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Janssen Biotech, Inc. | 3 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, Bimzelx, OTEZLA, TALTZ, SKYRIZI, COSENTYX, TREMFYA, ILUMYA.
Industry payments across AR — which companies pay providers there.
